EUVIMEDEUVIMED entdecken
Open Access

Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance

Catherine H Bozio, Kristen A Butterfield, Melissa Briggs Hagen, Shaun Grannis iD, Paul Drawz, Emily Hartmann, Toan C Ong, Bruce Fireman, Karthik Natarajan iD, Kristin Dascomb, Manjusha Gaglani iD, Malini B DeSilva iD und 18 weitere

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiad040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Catherine H Bozio und 29 weiteren Autor:innen. Beteiligte Einrichtung: COVID-19 Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data assessing protection conferred from COVID-19 mRNA vaccination and/or prior SARS-CoV-2 infection during Delta and Omicron predominance periods in the United States are limited.

Methods

This cohort study included persons ≥18 years who had ≥1 health care encounter across 4 health systems and had been tested for SARS-CoV-2 before 26 August 2021. COVID-19 mRNA vaccination and prior SARS-CoV-2 infection defined the exposure. Cox regression estimated hazard ratios (HRs) for the Delta and Omicron periods; protection was calculated as (1−HR)×100%.

Results

Compared to unvaccinated and previously uninfected persons, during Delta predominance, protection against COVID-19–associated hospitalizations was high for those 2- or 3-dose vaccinated and previously infected, 3-dose vaccinated alone, and prior infection alone (range, 91%–97%, with overlapping 95% confidence intervals [CIs]); during Omicron predominance, estimates were lower (range, 77%–90%). Protection against COVID-19–associated emergency department/urgent care (ED/UC) encounters during Delta predominance was high for those exposure groups (range, 86%–93%); during Omicron predominance, protection remained high for those 3-dose vaccinated with or without a prior infection (76%; 95% CI = 67%–83% and 71%; 95% CI = 67%–73%, respectively).

Conclusions

COVID-19 mRNA vaccination and/or prior SARS-CoV-2 infection provided protection against COVID-19–associated hospitalizations and ED/UC encounters regardless of variant. Staying up-to-date with COVID-19 vaccination still provides protection against severe COVID-19 disease, regardless of prior infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansAdultSARS-CoV-2COVID-19 VaccinesCohort StudiesVaccinationRNA, Messenger

Stichwörter der Autor:innen

COVID-19 vaccinationCOVID-19–associated hospitalizationsOmicron variantprior SARS-CoV-2 infectionprotection

Substanzen

COVID-19 VaccinesRNA, Messenger

Autor:innen und Institutionen

  • COVID-19 Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Westat, Rockville, Maryland, USA.
  • Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.
  • School of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Division of Nephrology and Hypertension, University of Minnesota, Minneapolis, Minnesota, USA.
  • Paso Del Norte Health Information Exchange, El Paso, Texas, USA.

ORCID-Profile: Shaun Grannis, Karthik Natarajan, Manjusha Gaglani, Malini B DeSilva, Brian E Dixon

Förderung

  • Intramural CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Bozio, C. H., Butterfield, K. A., Briggs Hagen, M., Grannis, S., Drawz, P., Hartmann, E., Ong, T. C., Fireman, B., Natarajan, K., Dascomb, K., Gaglani, M., DeSilva, M. B., Yang, D. H., Midgley, C. M., Dixon, B. E., Naleway, A. L., Grisel, N., Liao, I. C., Reese, S. E., …, & Stenehjem, E. (2023). Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad040

Vancouver

Bozio CH, Butterfield KA, Briggs Hagen M, Grannis S, Drawz P, Hartmann E, et al. Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad040

BibTeX
@article{Bozio2023,
  author = {Bozio, Catherine H and Butterfield, Kristen A and Briggs Hagen, Melissa and Grannis, Shaun and Drawz, Paul and Hartmann, Emily and Ong, Toan C and Fireman, Bruce and Natarajan, Karthik and Dascomb, Kristin and Gaglani, Manjusha and DeSilva, Malini B and Yang, Duck-Hye and Midgley, Claire M and Dixon, Brian E and Naleway, Allison L and Grisel, Nancy and Liao, I Chia and Reese, Sarah E and Fadel, William F and Irving, Stephanie A and Lewis, Ned and Arndorfer, Julie and Murthy, Kempapura and Riddles, John and Valvi, Nimish R and Mamawala, Mufaddal and Embi, Peter J and Thompson, Mark G and Stenehjem, Edward},
  title = {Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiad040}
}
Kostenlos starten →